US FDA to convene expert panel to review wider access to some peptides Click the link in the comments below. The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA's Overreach on Compounded Peptides The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law